Content
Frontiers of Medicine >> 2023, Volume 17, Issue 2 doi: 10.1007/s11684-022-0945-y
A small-molecule pan-HER inhibitor alone or in combination with cisplatin exerts efficacy against nasopharyngeal carcinoma
Abstract
Keywords
epidermal growth factor receptor ; ErbB receptors ; HM781-36B ; nasopharyngeal carcinoma ; molecular targeted therapy ; cisplatin
Content